» Articles » PMID: 8353921

Concordance and Discordance Between Stress-redistribution-reinjection and Rest-redistribution Thallium Imaging for Assessing Viable Myocardium. Comparison with Metabolic Activity by Positron Emission Tomography

Overview
Journal Circulation
Date 1993 Sep 1
PMID 8353921
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Stress thallium scintigraphy provides important diagnostic and prognostic information in patients with coronary artery disease by demonstrating regional myocardial ischemia. However, if the clinical question being addressed is whether a region is viable and not whether there is inducible ischemia, then it may be more reasonable to perform rest-redistribution imaging rather than stress-redistribution imaging followed by either reinjection or late redistribution. Therefore, we determined whether stress-redistribution-reinjection and rest-redistribution imaging provide the same information regarding myocardial viability.

Methods And Results: Both stress-redistribution-reinjection and rest-redistribution thallium single photon emission computed tomographic imaging was performed in 41 patients with chronic stable coronary artery disease, with quantitative analysis of regional thallium activity. Thallium reinjection was performed immediately after the 3- to 4-hour redistribution images were completed. Of the 155 myocardial regions with perfusion defects on the stress images, 91 (59%) were irreversible on conventional 3- to 4-hour redistribution images. When the outcomes of these irreversible regions were assessed after reinjection and compared with rest-redistribution images, there was concordance of data regarding myocardial viability (normal/reversible or irreversible) in 72 of the 91 (79%) irreversible defects. Twenty of the 41 patients also underwent positron emission tomography at rest with [18F]fluorodeoxyglucose and [15O]water. In these patients, stress-redistribution-reinjection and rest-redistribution imaging provided concordant information regarding myocardial viability in 427 (72%) of 594 myocardial regions and discordance in 167 regions. However, when irreversible thallium defects were further analyzed according to the severity of the thallium defect in these discordant regions, 149 of 167 (89%) demonstrated only mild-to-moderate reduction in thallium activity (51% to 85% of normal activity), and positron emission tomography verified 98% of these regions to be metabolically active and viable. Thus, when the severity of thallium activity was considered within irreversible thallium defects, the concordance between stress-redistribution-reinjection and rest-redistribution imaging regarding myocardial viability increased to 94%.

Conclusions: These data indicate that one of two imaging modalities, either stress-redistribution-reinjection or rest-redistribution imaging, may be used for identifying viable myocardium. However, if there are no contraindications to stress testing, stress-redistribution-reinjection imaging provides a more comprehensive assessment of the extent and severity of coronary artery disease by demonstrating regional myocardial ischemia without jeopardizing information on myocardial viability.

Citing Articles

Myocardial perfusion and function single photon emission computed tomography.

Hansen C, Goldstein R, Berman D, Churchwell K, Cooke C, Corbett J J Nucl Cardiol. 2006; 13(6):e97-120.

PMID: 17174800 DOI: 10.1016/j.nuclcard.2006.08.008.


Biphasic response to dobutamine predicts improvement of left ventricular dysfunction after revascularization: correlation with positron emission and rest-redistribution 201Tl tomographies.

Hernandez-Pampaloni M, Peral V, Carreras J, Sanchez-Harguindey L, Vilacosta I Int J Cardiovasc Imaging. 2003; 19(6):519-28.

PMID: 14690191 DOI: 10.1023/b:caim.0000004302.68305.80.


Selective intracoronary injection of sestamibi to detect myocardial viability: Prediction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty.

Trani C, Giordano A, Lombardo A, Lupi A, Reale F, Patrizi R J Nucl Cardiol. 2003; 10(5):473-81.

PMID: 14569240 DOI: 10.1016/s1071-3581(03)00522-1.


Tl-201 reinjection enhances the detection of myocardial ischemia after acute myocardial infarction.

Dakik H, Mahmarian J J Nucl Cardiol. 2003; 10(2):117-20.

PMID: 12673175 DOI: 10.1067/mnc.2003.20.


Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Kailasnath P, Sinusas A J Nucl Cardiol. 2001; 8(4):482-98.

PMID: 11481571 DOI: 10.1067/mnc.2001.115078.